Cytochrome P450 1A isoenzymes in brain cells: Expression and inducibility in cultured rat brain neuronal and glial cells

Life Sciences

Volumn 79, Issue 25, 2006, Pages 2387-2394

  Kapoor, Nidhi ^a   Pant, Aditya B ^b   Dhawan, Alok ^b   Dwievedi, Uppendra N ^a   Seth, Prahlad K ^b   Parmar, Devendra ^b  

^a UNIVERSITY OF LUCKNOW   (India)

^b CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

Cytochrome P450 1A; Enzyme; Glia; Induction; mRNA; Neurons

Indexed keywords

3 METHYLCHOLANTHRENE; 7 ETHOXYCOUMARIN DEETHYLASE; CYTOCHROME P450 1A; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CELL; BRAIN MICROSOME; CELL TYPE; CONTROLLED STUDY; DETOXIFICATION; EMBRYO; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; GLIA CELL; IMMUNOCYTOCHEMISTRY; NERVE CELL CULTURE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; XENOBIOTIC METABOLISM;

ANIMALS; BRAIN; CELLS, CULTURED; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; ENZYME INDUCTION; FEMALE; IMMUNOENZYME TECHNIQUES; ISOENZYMES; METHYLCHOLANTHRENE; MICROSOMES; NEUROGLIA; NEURONS; PREGNANCY; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33751084592     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.08.002     Document Type: Article

References (38)

1. Abdulla D., and Renton K.W. Beta-adrenergic receptor modulation of the LPS-mediated depression in CYP1A activity in astrocytes. Biochemical Pharmacology 69 (2005) 741-750
2. Agundez J.A., Gallardo L., Martinez C., Gervasini G., and Benitez J. Modulation of CYP1A2 enzyme activity by indoleamines: inhibition by serotonin and tryptamine. Pharmacogenetics 8 (1998) 251-258
3. Anandatheerthavarada H.K., Shankar S.K., and Ravindranath V. Rat brain cytochromes P-450: catalytic, immunochemical properties and inducibility of multiple forms: Preparation of brain microsomes with cytochrome P450 activity using calcium aggregation method NADPH cytochrome P-450 reductase in rat, mouse and human brain. Brain Research 536 (1990) 339-343
4. Cherng S.H., Lin P., Yang J.L., Hsu S.L., and Lee H. Benzo[g,h,i]perylene synergistically transactivates benzo[a]pyrene-induced CYP1A1 gene expression by aryl hydrocarbon receptor pathway. Toxicology and Applied Pharmacology 170 (2001) 63-68
5. Eaton D.L., Gallagher E.P., Bammler T.K., and Kunze K.L. Role of cytochrome P450 1A2 in chemical carcinogenesis: implications for human variability in expression and enzyme activity. Pharmacogenetics 5 (1995) 259-274
6. Filbrandt C.R., Wu Z., Zlokovic B., Opanashuk L., and Gasiewicz T.A. Presence and functional activity of the aryl hydrocarbon receptor in isolated murine cerebral vascular endothelial cells and astrocytes. Neurotoxicology 25 (2004) 605-616
7. Gervasini G., Carrillo J.A., and Benitez J. Potential role of cerebral cytochrome P450 in clinical pharmacokinetics: modulation by foreign chemicals. Clinical Pharmacokinetics 43 (2004) 693-706
8. Gonzalez F.J., Matsunaga T., and Nagata K. Structure and regulation of P-450s in the rat P450IIA gene subfamily. Drug Metabolism Reviews 20 (1989) 827-837
9. Guengerich F.P. Characterization of roles of human cytochrome P450 enzymes in carcinogen metabolism. Asia Pacific Journal of Pharmacology 5 (1990) 327-345
10. Hedlund E., Gustafsson J.A., and Warner M. Cytochrome P450 in the brain; a review. Current Drug Metabolism 2 (2001) 245-263
11. Hodgson A.V., White T.B., White J.W., and Strobel H.W. Expression analysis of the mixed function oxidase system in rat brain by the polymerase chain reaction. Molecular and Cellular Biochemistry 120 (1993) 171-179
12. Johri A., Dhawan A., Singh R.L., and Parmar D. Effect of prenatal exposure of deltamethrin on the ontogeny of xenobiotics metabolizing cytochrome P450s in the brain and liver of offsprings. Toxicology and Applied Pharmacology 214 (2006) 279-289
13. Kainu T., Gustafsson J.A., and Pelto-Huikko M. The dioxin receptor and its nuclear translocator (Arnt) in the rat brain. Neuroreport 6 (1995) 2557-2560
14. Kapitulnik J., Gelboin H.V., Guengerich F.P., and Jacobowitz D.M. Immunohistochemical localization of cytochrome P-450 in rat brain. Neuroscience 20 (1987) 829-833
15. Kapoor N., Pant A.B., Dhawan A., Dwievedi U.N., Gupta Y.K., Seth P.K., and Parmar D. Differences in sensitivity of cultured rat brain neuronal and glial cytochrome P450 2E1 to ethanol. Life Sciences (2006) (May 7, Electronic publication ahead of print)
16. Kohler C., Eriksson L.G., Hansson T., Warner M., and Ake-Gustafsson J. Immunohistochemical localization of cytochrome P-450 in the rat brain. Neuroscience Letters 84 (1988) 109-114
17. Konstandi M., Johnson E.O., Marselos M., Kostakis D., Fotopoulos A., and Lang M.A. Stress-mediated modulation of B(alpha) P-induced hepatic CYP1A1: role of catecholamines. Chemical Biological Interactions 147 (2004) 65-77
18. Konstandi M., Kostakis D., Harkitis P., Marselos M., Johnson E.O., Adamidis K., and Lang M.A. Role of adrenoceptor-linked signaling pathways in the regulation of CYP1A1 gene expression. Biochemical Pharmacology 69 (2005) 277-287
19. Legare M.E., Hanneman W.H., Barhoumi R., and Tiffany-Castiglioni E. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure in primary rat astroglia: identification of biochemical and cellular targets. Neurotoxicology 18 (1997) 515-524
20. Lucas D., Berthou F., Girre C., Poitrenaud F., and Menez J.F. High-performance liquid chromatographic determination of chlorzoxazone and 6-hydroxychlorzoxazone in serum: a tool for indirect evaluation of cytochrome P450 2E1 activity in humans. Journal of Chromatography 622 (1993) 79-86
21. Martinez C., Gervasini G., Agundez J.A., Carrillo J.A., Ramos S.I., Garcia-Gamito F.J., Gallardo L., and Benitez J. Modulation of midazolam 1-hydroxylation activity in vitro by neurotransmitters and precursors. European Journal of Clinical Pharmacology 56 (2000) 145-151
22. Miksys S.L., and Tyndale R.F. Drug metabolizing cytochrome P450s in the brain. Journal of Psychiatry Neuroscience 27 (2002) 406-415
23. Miksys S.L., Hoffman E., and Tyndale R.F. Regional and cellular induction of nicotine metabolizing CYP2B1 in rat brain by chronic nicotine treatment. Biochemical Pharmacology 59 (2000) 1501-1511
24. Nebert D.W., and Jones J.E. Regulation of the mammalian cytochrome P1-450 (CYP1A1) gene. International Journal of Biochemistry 21 (1989) 243-252
25. Nelson D.R., Koymans L., Kamataki T., Stegeman J.J., Feyereisen R., Waxman D.J., Waterman M.R., Gotoh O., Coon M.J., Estrabrook R.W., Gunsalus I.C., and Nebert D.W. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6 (1996) 1-42
26. Nicholson T.E., and Renton K.W. Modulation of cytochrome P450 by inflammation in astrocytes. Brain Research 827 (1999) 12-18
27. Nicholson T.E., and Renton K.W. Role of cytokines in the lipopolysaccharide-evoked depression of cytochrome P450 in the brain and liver. Biochemical Pharmacology 62 (2001) 1709-1717
28. Nicholson T.E., and Renton K.W. The role of cytokines in the depression of CYP1A activity using cultured astrocytes as an in vitro model of inflammation in the central nervous system. Drug Metabolism Disposition 30 (2002) 42-46
29. Nissbrandt H., Bergquist F., Jonason J., and Engberg G. Inhibition of cytochrome P450 2E1 induces an increase in extracellular dopamine in rat substantia nigra: a new metabolic pathway?. Synapse 40 (2001) 294-301
30. Omiecinski C.J., Redlich C.A., and Costa P. Induction and developmental expression of cytochrome P450 IA1 messenger RNA in rat and human tissues: detection by the polymerase chain reaction. Cancer Research 50 (1990) 4315-4321
31. Parmar D., Dhawan A., and Seth P.K. Immunochemical evidence for the presence of phenobarbital (PB) and 3-methylcholanthrene (MC) inducible cytochrome P450 isoenzymes in rat brain. International Journal of Toxicology 17 (1998) 619-630
32. Parmar D., Dayal M., and Seth P.K. Expression of cytochrome P450s (P450s) in brain: physiological, pharmacological and toxicological consequences. Proceedings of Indian National Academy of Sciences vol. 6 (2003) 905-928
33. Pravettoni A., Colciago A., Negri-Cesi P., Villa S., and Celotti F. Ontogenetic development, sexual differentiation, and effects of Aroclor 1254 exposure on expression of the arylhydrocarbon receptor and of the arylhydrocarbon receptor nuclear translocator in the rat hypothalamus. Reproductive Toxicology 20 (2005) 521-530
34. Schilter B., and Omiecinski C.J. Regional distribution and expression modulation of cytochrome P-450 and epoxide hydrolase mRNAs in the rat brain. Molecular Pharmacology 44 (1993) 990-996
35. Strobel H.W., Thompson C.M., and Antonovic L. Cytochromes P450 in brain: function and significance. Current Drug Metabolism 2 (2001) 199-214
36. Takanaga H., Kunimoto M., Adachi T., Tohyama C., and Aoki Y. Inhibitory effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on cAMP-induced differentiation of rat C6 glial cell line. Journal of Neuroscience Research 64 (2001) 402-409
37. Tsuchiya Y., Nakajima M., and Yokoi T. Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Letters 227 (2005) 115-124
38. Warner M., Kohler C., Hansen T., and Gustafsson J.A. Regional distribution of cytochrome P450 in the rat brain: spectral quantification and contribution of P450b,e and P450c,d. Journal of Neurochemistry 50 (1988) 1057-1065